|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Acorda Therapeutics (NASDAQ: ACOR) through any online brokerage.
The latest price target for Acorda Therapeutics (NASDAQ: ACOR) was reported by HC Wainwright & Co. on June 17, 2021. The analyst firm set a price target for 10.00 expecting ACOR to rise to within 12 months (a possible 269.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Acorda Therapeutics (NASDAQ: ACOR) is $2.71 last updated Tue Dec 07 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Acorda Therapeutics.
Acorda Therapeutics’s $Q4 earnings are confirmed for after-market on March 3, 2022.
There is no upcoming split for Acorda Therapeutics.
Acorda Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.